Celltrion Healthcare Ranks High in Search... Stock Price Up 0.23%
As of 12:31 PM on the 13th, Celltrion Healthcare is trading at 172,400 KRW, up 0.23% from the previous day. This marks a 14.7% increase compared to January 6. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have a net purchase of 7,000 shares of Celltrion Healthcare, while institutions have a net sale of 1,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 697,307 shares, while foreigners and institutions have net sold 723,679 shares and 10,896 shares, respectively.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- NVIDIA Reports $81.6 Billion in Q1 Revenue, Surpassing Expectations
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
